The cluster is too small and stale to signal a catalyst. Monitor upcoming 10-Q for managed-care margin trends and pharmacy benefit margin commentary — those drive Cigna's earnings, not stale 13F rebalancing.
Executive Summary
Three institutional asset managers (Assenagon, Robeco, Concurrent) accumulated $85.7M in Cigna Group shares during Q3 2026, while two managers trimmed $20.2M. The net $65.5M inflow is dominated by a 203% position doubling from Assenagon, but the cluster is small (3 buyers, 2 sellers) and all participants are conventional asset managers rather than high-conviction activists or activists. The signal is modest and stale (45-day lag), suggesting routine portfolio rebalancing rather than a catalyst-driven thesis.
Key Financial Metrics
Institutional Positions
Net institutional flow: $65.5M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | DOUBLED | +203% | $85.4M | $56.8M |
| Concurrent Investment Advisors | ADD | +30.5% | $3.1M | $687.0K |
| Robeco Institutional Asset Management B.v. | ADD | +57.2% | $79.5M | $28.2M |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Wealth Enhancement Advisory Services | TRIM | -34.9% | $49.4M | -$19.2M |
| Mather Group | TRIM | -61.1% | $1.6M | -$998.0K |
Key Facts
- 3 institutional buyers added $85.7M in new value; 2 sellers reduced by $20.2M
- Assenagon Asset Management doubled its position (+203%, $56.8M increase) to $85.4M
- Robeco Institutional Asset Management added 57.2% (+$28.2M) to $79.5M
- Wealth Enhancement Advisory Services trimmed 34.9% (-$19.2M) to $30.2M
- Mather Group trimmed 61.1% (-$998K) to $621K
- All five participants are conventional asset managers; no activist or hedge fund involvement
- 13F data is ~45 days stale; positions reflect quarter-end holdings, not current
Financial Impact
Net institutional inflow of $65.5M (buyers added $85.7M, sellers reduced $20.2M) across 5 managers; largest single move was Assenagon's $56.8M increase
Risk Factors
- 13F data is backward-looking; positions may have been unwound since quarter-end
- All participants are passive/active asset managers with no activist or insider buying — no high-conviction signal
- Small sample (3 buyers, 2 sellers) limits statistical significance
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CI-2026-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Institutional Cluster | $304.68 | awaiting T+60 | awaiting T+60 | No price |
Oct 20, 2026 7d ago | Institutional Cluster | $304.37 | awaiting T+60 | awaiting T+60 | No price |
Oct 9, 2026 18d ago | 8-K | $283.34 | awaiting T+60 | awaiting T+60 | No price |
Sep 30, 2026 27d ago | 8-K | $271.83 | awaiting T+60 | awaiting T+60 | No price |
Sep 3, 2026 7w ago | 144 | $286.26 | awaiting T+60 | awaiting T+60 | No price |
Aug 18, 2026 10w ago | 144 | $278.50 | awaiting T+60 | awaiting T+60 | No price |
Aug 4, 2026 12w ago | 144 | $273.45 | awaiting T+60 | awaiting T+60 | No price |
Jul 9, 2026 15w ago | 3 | $293.46 $271.29 | ▼ −7.55% | ▼ −10.19% | No price |
May 13, 2026 23w ago | 8-K | $300.42 $281.56 | ▼ −6.28% | ▼ −10.45% | No price |
May 6, 2026 25w ago | Court Ruling | $284.04 $274.05 | ▼ −3.52% | ▼ −8.95% | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers